$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Buccal, polar and non-polar spray containing ondansetron 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/4178
  • A61K-009/08
  • A61K-009/00
  • A61K-031/573
  • A61K-047/10
출원번호 US-0445331 (2012-04-12)
등록번호 US-9078816 (2015-07-14)
발명자 / 주소
  • Dugger, III, Harry A.
  • Abd El-Shafy, Mohammed
출원인 / 주소
  • Suda Ltd.
대리인 / 주소
    Marshall, Gerstein & Borun LLP
인용정보 피인용 횟수 : 0  인용 특허 : 62

초록

Buccal aerosol sprays or capsules using polar and non-polar solvents have now been developed which provide ondansetron for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: aqueous polar solvent, ondans

대표청구항

1. A propellant free oral spray composition for transmucosal administration of ondansetron or a pharmaceutically acceptable salt thereof comprising: ondansetron or a pharmaceutically acceptable salt thereof in an amount of between 0.01 and 40 percent by weight of the total composition; anda mixture

이 특허에 인용된 특허 (62)

  1. Nagy Margit (Budapest HUX) Kenderfi Jzsef (Budapest HUX) Grgnyi Frigyes (Budapest HUX) Csrgo Margit (Budapest HUX) Fedina Lidia (Budapest HUX) Mosonyi Antal (Krmend HUX) Vajas Sndor (Krmend HUX) Mndi, Aerosol composition comprising nitroglycerin as active ingredient.
  2. Adjei Akwete L. (Wadsworth IL) Gupta Pramod K. (Gurnee IL) Lee Dennis Y. (Highland Park IL), Aerosol drug formulations containing vegetable oils.
  3. Schmolka Irving R. (Grosse Ile MI), Aerosol gel.
  4. Penkler,Lawrence John, Alprazolam inclusion complexes and pharmaceutical compositions thereof.
  5. Jao Francisco (San Jose CA) Huynh Hoa I. (Fremont CA) Wong Patrick S. L. (Palo Alto CA), Antiemetic therapy.
  6. Sawaya Assad S. (9 Lyn La. Baiting Hollow NY 11933), Antifungal formulation.
  7. Kim Soo-Il, Aqueous-based pharmaceutical composition.
  8. Viegas Tacey X. (Ann Arbor MI) Reeve Lorraine E. (Ann Arbor MI) Henry Raymond L. (Grosse Pointe Woods MI), Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels.
  9. Dugger ; III Harry A., Buccal non polar spray or capsule.
  10. Dugger ; III Harry A., Buccal polar spray or capsule.
  11. Dugger ; III Harry A., Buccal, non-polar spray for nitroglycerin.
  12. Dugger, III,Harry A., Buccal, polar and non-polar spray or capsule.
  13. Dugger, III., Harry A., Buccal, polar and non-polar spray or capsule.
  14. Dugger, III, Harry A., Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system.
  15. Dugger, III, Harry A., Buccal, polar and non-polar spray or capsule containing drugs for treating pain.
  16. Jones Brian E. (Basingstoke GB2) Knight Paula M. (Wolverhampton GB2) Walker Mark A. (Basingstoke GB2), Chewable capsules.
  17. Borkan Lionel (New Vernon NJ) Berry Ira R. (Westfield NJ) Shah Dilip (Flanders NJ), Chewable, edible soft gelatin capsule.
  18. Wang Yu-chang J. (Los Altos CA) Lee William A. (Los Altos CA) Narog Blair (Palo Alto CA), Composition and method for administration of pharmaceutically active substances.
  19. Kanios David P. ; Gentile Joseph A. ; Mantelle Juan A. ; Sablotsky Steven, Compositions and methods for topical administration of pharmaceutically active agents.
  20. Ko Kenneth D. ; Anderton David O. ; Eldumiati Ismail I. ; Gronemeyer Steven A. ; Harmer Don L. ; Henderson P. Michael ; Peshkin Joel D. ; Rahamim Raphael ; Stubbe Frederic M. ; Walley John S. ; Walle, Constant envelope modulation for splitterless DSL transmission.
  21. Dvorsky Stephan (Binningen CHX) Radivojevich Franz (Zofingen CHX) Joss Hans (Murgenthal CHX), Coronary therapeutic agent in the form of soft gelatin capsules.
  22. Shashoua Victor E. ; Swindell Charles S. ; Webb Nigel L. ; Bradley Matthews O., DHA-pharmaceutical agent conjugates of taxanes.
  23. Keller Brian C. ; Fisher Daniel L. ; Kiss Steven, Delivery of biologically active material in a liposomal formulation for administration into the mouth.
  24. Lacy Jonathan Ernest (Swindon GBX) Embleton Jonathan Kenneth (Berkshire GBX), Delivery systems for hydrophobic drugs.
  25. Reed Barry Leonard,AUX ; Morgan Timothy Matthias,AUX ; Finnin Barrie Charles,AUX, Dermal penetration enhancers and drug delivery systems involving same.
  26. Hegasy Ahmed (Leverkusen DEX) Rmsch Klaus-Dieter (Wuppertal DEX), Dihydropyridine spray, process for its preparation and its pharmaceutical use.
  27. Dixit Suresh C. (Neshamic Station NJ) Goldman David (Hillsdale NJ) Hu John J. (Huntington CT) Sethachutkul Krish (Scarsdale NY), Dispersing agents for use with hydrofluoroalkane propellants.
  28. Jinks Philip A. (Mountsorrel GB3) Bell Alexander (Chilwell GB3) Fischer Franz X. (Riehen CHX), Drug-containing chlorofluorocarbon aerosol propellent formulations.
  29. Robinson Joseph R. ; McGinity James W., Effervescent granules and methods for their preparation.
  30. Parnell Francis W. (Ross CA), Eriodictyon compositions and methods for treating internal mucous membranes.
  31. Johnson Leslie Sid, Human-murine chimeric antibodies against respiratory syncytial virus.
  32. Hersh Theodore, Intra-oral antioxidant preparations.
  33. Dickinson, Jeffrey; Khan, Karrar Ahmad; Hague, John Neville; Smith, Alan, Liquid pharmaceutical compositions comprising thyroid hormones.
  34. Jeffrey Dickinson GB; Karrar Ahmad Khan GB; John Neville Hague GB; Alan Smith GB, Liquid pharmaceutical compositions comprising thyroid hormones.
  35. Doherty ; Jr. Paul C. ; Place Virgil A. ; Smith William L., Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction.
  36. Purewal Tarlochan S. (Leamington Spa GB2) Greenleaf David J. (Loughborough GB2), Medicinal aerosol formulations.
  37. Purewal Tarlochan S.,GB2 ; Greenleaf David J.,GB2, Medicinal aerosol formulations.
  38. Baker R. W. (Palo Alto CA) Santus Gian C. (Milan CA ITX) Vintilla-Friedman S. (Cupertino CA), Method and therapeutic system for smoking cessation.
  39. Baker Richard W. (Palo Alto CA) Santus Giancarlo (Milan ITX) Vintilla-Friedman Susan (Cupertino CA), Method and therapeutic system for smoking cessation.
  40. Spector John E. (2404 Sacada Cir. La Costa CA 92009), Method for oral spray administration of caffeine.
  41. Prince Gregory A. (Potomac MD) Hemming Val G. (Gaithersburg MD), Method for treating infectious respiratory diseases.
  42. Daniel David G. (6408-P Seven Corners Pl. Falls Church VA 22044), Method for treatment of recurrent paroxysmal neuropsychiatric.
  43. Bechgaard Erik (Hellerup DKX) Gizurarson Sveinbjrn (Keflavik ISX) Hjortkjaer Rolf K. (Humlebaer DKX), Method of administering a biologically active substance.
  44. Hammesfahr William M., Method of diagnosis and treatment and related compositions and apparatus.
  45. Farr Stephan J.,GBX ; Rowe Antony M.,GBX ; Rubsamen Reid, Method of intrapulmonary administration of a narcotic drug.
  46. Simon David Lew, Methods for improved regulation of endogenous dopamine in prolonged treatment of opioid addicted individuals.
  47. Lee, Andrew G.; Day, Wesley W.; Thompson, David D., Methods of treatment for premature ejaculation in a male.
  48. Cholcha Walter (Elmshorn DEX), Nitroglycerin pump spray.
  49. Aouda Yukio (Tokyo JPX) Ninomiya Hiroshi (Sayama JPX) Izu Genichi (Saitama JPX) Yazawa Yuichi (Tokyo JPX) Tachibana Megumi (Tokyo JPX), Nitroglycerin spray.
  50. Fassberg Julianne (New York NY) Sequeira Joel A. (New York NY) Chaudry Imtiaz A. (North Caldwell NJ) Kopcha Michael (East Brunswick NJ), Non-chlorofluorocarbon aerosol formulations.
  51. Patel Dinesh C. (Murray UT) Chang Yunik (Lakewood NJ), Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols.
  52. Morimoto Yasunori (7-22 ; Nishisakado 4-chome Sakado-shi ; Saitama-ken ; 350-02 JPX) Sugibayashi Kenji (Sakado JPX) Kobayashi Kouji (Tokyo JPX) Kusano Hisashi (Ageo JPX), Percutaneously absorbable compositions of morphine or analogous analgesics of morphine.
  53. Pankaj Modi CA, Pharmaceutical compositions for buccal and pulmonary application.
  54. Klokkers-Bethke Karin (Monheim/Rhld. DEX) Mnch Ulrich (Monheim/Rhld. DEX), Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina.
  55. Burghart Walter (A-1030 Vienna ; Salmgasse 4 Vienna ATX) Burghart Kurt (D-2217 Rosdorf ; Saegeberg 8 Rosdorf DEX), Pharmaceutical preparation and methods for its production.
  56. Patton John S. (San Carlos CA), Pulmonary delivery of active fragments of parathyroid hormone.
  57. Deihl Joseph A., Sprayable analgesic composition and method of use.
  58. Stanislaus Friedrich (Munich DEX) Hofer Josef M. (Kirchseeon DEX) Knoch Axel (Munich DEX), Sprayable pharmaceutical composition for topical use.
  59. Popli Shankar D. (Marlton NJ) Go Zenaida O. (Hammonton NJ), Taste masking pseudoephedrine HCL containing liquids.
  60. Gottlieb Roberta A. ; Babior Bernard M., Treatment of viscous mucous-associated diseases.
  61. Singer Robert E. (Fairfield OH) Ebel James P. (Cincinnati OH), Use of H-2 antagonists for treatment of gingivitis.
  62. Maehata, Takashi, Vehicle-to-roadside communication system, roadside communication station, and on-board mobile station.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로